Bristol-Backed Program May Spur Immunotherapy Use In Community Setting

With Yervoy/Opdivo melanoma combo and Keytruda lung cancer approvals right around the corner, a new educational program from the Association of Community Cancer Centers aims to encourage immunotherapy adoption outside of academic centers.